Антифосфолипидный синдром - Насонов Е.Л.
ISBN 5-98216-010-5
Скачать (прямая ссылка):
SHS-OOO4.qxd 21.11.2006 16:56 Page
ГЛАВА 5. Патогенетические механизмы антифосфолипидного синдрома
136. Perry GJ, Elston T, Khouri NA, et al. Anti-endothelial cell antibodies in lupus: correlation with renal injury anf circulating marker of endothelial damage. Q J Med 1993; 86: 727—734.
137. Chan TM, Yu PM, Tsang LC, Cheng IKP. Endothelial cell binding by human polyclonal anti-DNA antibodies: relationship to disease activity and endothelial function alteration. Clin Exp Immunol 1995; 100: 506—513.
138. Del Papa N, Guidali L, Spatola L, et al. Relationship between anti-phospholipid and antiendothelial vell antibodies III: beta 2 glyco-protein I mediates the antibody binding to endothelial membranes and induce the expression of adhesion molecules. Clin Exp Rheumatol 1995; 13: 179—185.
139. Garvalho D, Savage COS, Isenberg D, Pearson JD. IgG anti-endothelial cell autoanti-bodies from patients with systemic lupus erythe-matosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 1999; 42: 631—640.
140. McGrae KR, de Michele A, Samuels P, et al. Detection of endothelial cell reactive immunoglobulin in patients with anti-phospholipid antibodies. Br J Heamatol 1991; 79: 595—605.
141. Del Papa N, Raschini E, Moroni G, et al. Anti-endothelial cell IgG fraction from sysyemic lupus erythematosus patients bind to human endothelial cell and induce a pro-adhesive and pro-inflammatory phenotype in vitro. Lupus 1999; 8: 423—429.
142. Hill MB, Philips JL, Hughes P, Greaves M. Anti-endothelial cell antibodies in primary antiphospholipid syndrome and SLE: pattern of reactivity with membrane antigens on microvas-cular and umbilical venous cell membranes. Br J Haematol. 1998; 103: 416—421.
143. Насонов ЕЛ, Алекберова ЗС, Саложин КВ, Клюквина НГ, Александрова ЕН, Баранов АА, Ле Тонкез М, Юну П. Антиэндотелиаль-ные антитела при системной красной волчанке у мужчин: связь с поражением почек и антифосфолипидным синдромом. Терапевт. архив, 1996; 6: 46—49.
144. Калашникова ЛА, Саложин КВ, Насонов ЕЛ, Кошелева НМ, Решетняк ТМ, Сто-
янович ЛЗ. Антитела к эндотелию при синдроме Снеддона. Терапевт. архив, 1996; 1: 54—57.
145. Frances G, Le Tonqueze M, Salozhin K, Kalasdhnikova L, Piette J-C, Nasonov EL, Godeau P, Youinou P. Prevalence of anti-endothelial cell antibodies in patients with Sneddon's syndrome. J Amer Acad Dermatol 1995; 33: 64—68.
146. Насонов ЕЛ, Саложин КВ, Фомичева ОА, Клюквина НГ, Карпов ЮА, Вильчинская МЮ, Александрова ЕН, Алекберова ЗС, Баранов АА, Сергакова ЛМ. Антиэндотелиаль-ные антитела и поражение клапанов сердца при антифосфолипидном синдроме: анализ патогенетических механизмов. Клин. медицина, 1997; 2: 17—21.
147. Cervera R, Khamashta MA, Font J, et al. Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity 1991; 11: 1—6.
148. Walker TS, Triplett DA, Javed N, et al. Evaluation of lupus anticoagulants: antiphospho-lipid antibodies, endothelium associated im-munoglobulin in patients with anti-phospholipid antibodies Thromb Res 1988; 51: 595—605.
149. Garcia-Torress R, Amogo M-C, de la Rossa A, Reyes PA. Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings. Lupus 1996; 5: 56—61.
150. Guilly MN, Danon F, Brouet JC, et al. Autoantibodies to nuclear lamin B in patients with thrombocytopenia. Eur J Cell Biol 1987; 43: 266—272.
151. Lassoued K, Guilly MN, Danon F, et al. Antinuclear autoantibodies specific for lamins: characterization and clinical significance. Ann Intern Med 1988; 108: 829—833.
152. Senecal J-L, Rauch J, Grodzicky T, et al. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus Arthritis Rheum 1999; 42: 1347—1353.
153. Клюквина НГ, Баранов ЕЛ, Александрова ЕН, Насонов ЕЛ. С-реактивный белок при системной красной волчанке у мужчин: связь с тромботическими осложнениями. Клин. медицина, 1997; 8: 24—26.
SHS-OOO4.qxd 21.11.2006 16:56 Page 108
Насонов Е.Л. Антифосфолипидный синдром.
-е-
154. Papo T, Piette J-C, Legao E, et al. T lymphocytes subsets in primary antiphospholipid syndrome. J Rheumatol 1994; 21: 2242—2245.
155. Arnett FC, Olsen ML, Anderson KL, Reveille JD. Molecular analysis of major histo-compatibility complex alleles associated with the lupus anticoagulant. J Clin Invest 191; 87: 1490—1495.
156. Loizou S, Cofiner C., Weetman AP, Walport MJ. Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders. Clin Exp Immunol 1992; 90: 434—439.
157. Kita Y, Sumida T, Iwamoto I, et al. V gene analysis of anti-cardiolipin antibodies from (NZWXBXSB) F1 mice. Immunology 1994; 82: 494—501.
158. Blank M, Krause I., Lanir N, et al. Transfer of experimental antiphоspholipid syndrome by bone marrow cell transplantation: the importance of the T cell. Arthritis Rheum 1995; 38: 115—122.
